Biden cut low-income populations off insulin
Driven by an indomitable desire to shake off Trump's legacy, Joe Biden has doubled the value of EpiPens by a single signature. Before the signing of the decree freezing Trump's December drug policy and postponing till March, EpiPens cost from $ 150 to $ 400, the current cost will increase to $ 1,500, and maybe up to $ 2,000.
"The HHS Thursday froze the former Trump administration's December drug policy that requires community health centers to pass on all their insulin and epinephrine discount savings to patients. Centers that don't pass on the savings wouldn't qualify for federal grants,” Bloomberg Law reported. "This freeze is part of the Biden administration's large-scale effort announced this week that will scrutinize the Trump administration's health policies. If the previous administration's policies raise 'fact, law, or policy' concerns, the Biden HHS will delay them and consult with the Office of Management and Budget about other actions."
Biden reversed Trump's Executive Order to reduce pricing for insulin and epinephrine.— Mary Vought (@MaryVought) January 22, 2021
Democrats want higher insulin prices? pic.twitter.com/w85pkIAchG
Biden's main sponsor, Bloomberg, defended the new president, accusing Trump of insulin being so cheap along the way.
“Biden enters the presidency with at least a dozen lawsuits waiting over Trump-era moves to lower drug prices, an issue the new administration will likely tackle in its own way. The Department of Health and Human Services under Biden inherits challenges to rules that tie drug reimbursement to cheaper foreign drug prices and allow medication imports from Canada. It also faces complaints over Trump’s push for drugmakers to ship discounted drugs bought by low-income health centers to commercial contract pharmacies,” a report for Bloomberg Government said.
Image: Phillip Bradshaw / Flickr